Hantavirus Infections – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

 Hantaviruses are a genus of the virus that has a different severity and presentation associated with, a family of viruses spread mainly by rodents and can cause varied disease syndromes in people. Hantaviruses may cause hantavirus pulmonary syndrome (HPS) or haemorrhagic fever with renal syndrome (HFRS). Each hantavirus serotype has a specific rodent host species and is spread to people via an aerosolized virus that is shed in urine, feces, and saliva, and less frequently by a bite from an infected host. HPS is a severe and fatal, respiratory disease in humans caused by infection with hantaviruses. In humans, the mortality rates vary from 12% (HFRS) to 40% (HCPS). Both diseases are acute febrile infections, usually acquired through inhalation of aerosols or dust particles contaminated with virus-containing rodent excreta. HFRS is characterized by renal failure and haemorrhagic manifestations that vary from petechiae to severe internal bleeding. Pneumonia and cardiovascular dysfunction are characteristics of HCPS. Increased permeability of microvascular endothelium seems to be a common effect of hantavirus infection. In the complex pathogenesis of hantavirus infection, it is suggested that not the direct viral cytopathology, but immune mechanisms may play an important role.

·       The annual incidence of HFRS ranges between 350,000 to 500,000 cases worldwide, the majority of cases reported from ASIA, Europe, and China.

 

Thelansis’s “Hantavirus Infections Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Hantavirus Infections treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Hantavirus Infections across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Hantavirus Infections Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Hantavirus Infections – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Hantavirus Infections, Hantavirus Infections market outlook, Hantavirus Infections competitive landscape, Hantavirus Infections market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)